WebDisclosure WebDisclosure
Basculer en Français
8691 Companies
150137 Keywords
85728 Articles
80534 Press releases
Headlines Articles Press releases Volo Solutions Remove
  1. Home
  2. Companies
  3. Volo Solutions
WebDisclosure
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 04/12/2024 at 16:05, 1 year 1 month ago

    Revolutionizing Patient Experience: Flyland Recovery Network’s Adoption of Volo iPads

    Technology In Healthcare Flyland Recovery Network Volo Solutions Patient Care Innovation Substance Abuse Treatment
  • BRIEF

    published on 04/12/2024 at 16:05, 1 year 1 month ago

    Révolutionner l'expérience des patients : adoption des iPad Volo par Flyland Recovery Network

    La Technologie Dans Les Soins De Santé Traitement De La Toxicomanie Réseau De Récupération Flyland Solutions Volo Innovation En Matière De Soins Aux Patients
  • PRESS RELEASE

    published on 04/12/2024 at 16:00, 1 year 1 month ago

    Revolutionizing Patient Experience: Flyland Recovery Network’s Facilities Implement Volo Bedside Tablets

    Flyland Recovery Network upgrades patient experience with Volo's iPad solution, enhancing treatment technology and personalizing therapeutic services. Cost savings and green initiatives also benefited
    Patient Experience Cost Savings Flyland Recovery Network Volo IPad Solution Treatment Technology
Accesswire
  • Published on 05/28/2025 at 14:30, 5 hours 6 minutes ago

    Volcon ePowersports Obtains Floor Plan Program with Dealer Direct Financing

  • Published on 05/28/2025 at 14:30, 5 hours 6 minutes ago

    Aspire Biopharma Holdings, Inc., Provides Development Update on BUZZ BOMB(TM), its New Sublingual Pre-Workout Supplement, Expected to Launch in Third Quarter of 2025

  • Published on 05/28/2025 at 14:30, 5 hours 6 minutes ago

    MIRA Pharmaceuticals to Participate in BIO 2025 in Boston and Highlights Ongoing Progress Across Clinical Program

  • Published on 05/28/2025 at 13:56, 5 hours 40 minutes ago

    QNX Launches QNX Hypervisor 8.0 to Accelerate Embedded Software Development

  • Published on 05/28/2025 at 13:45, 5 hours 51 minutes ago

    Wellgistics Health Strengthens Executive Team and Board with Strategic Appointments to Accelerate Scale and Drive Shareholder Value

View all ACCESSWIRE
EQS Group
  • Published on 05/28/2025 at 19:07, 28 minutes ago

    Fuller, Smith & Turner PLC: Transaction in own shares

  • Published on 05/28/2025 at 18:14, 1 hour 21 minutes ago

    Funding Circle Holdings plc: POS-Transaction in Own Shares

  • Published on 05/28/2025 at 18:09, 1 hour 26 minutes ago

    Vonovia SE: AGM approves €1.22 dividend and appoints Michael Rüdiger and Dr Marcus Schenck to the Supervisory Board

  • Published on 05/28/2025 at 18:09, 1 hour 26 minutes ago

    CPI Europe starts the 2025 financial year with solid performance

  • Published on 05/28/2025 at 17:53, 1 hour 42 minutes ago

    Original-Research: Intellego Technologies AB (von Montega AG): Buy

View all EQS
Les Echos
  • Published on 05/28/2025 at 18:39, 56 minutes ago

    Descriptif du programme de rachat d'actions - Mai 2025

  • Published on 05/28/2025 at 18:39, 56 minutes ago

    Description of share-buyback program - May 2025

  • Published on 05/28/2025 at 18:34, 1 hour 1 minute ago

    AXA a placé 1 milliard d’euros d’Obligations Restricted Tier 1 et 1 milliard d’euros d’Obligations Tier 2

  • Published on 05/28/2025 at 18:34, 1 hour 1 minute ago

    AXA announces the placement of Euro 1 billion Restricted Tier 1 Notes and Euro 1 billion Tier 2 Notes

  • Published on 05/28/2025 at 18:00, 1 hour 36 minutes ago

    Chiffre d’affaires 2024/2025

View all LES ECHOS COMFI WIRE

With webdisclosure.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

©Dissemination technology Webdisclosure.com - copyright 2025 SYMEX ECONOMICS all rights reserved

WebDisclosure

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

Contact Authors Cookies policy Terms and conditions Privacy policy